|

pemetrexed /carboplatin Clinical Trials

4 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 2: 3

Top Sponsors

  • Sichuan University1
  • Shenyang Sunshine Pharmaceutical Co., LTD.1
  • Betta Pharmaceuticals Co., Ltd.1
  • AstraZeneca1

Indications

  • Cancer4
  • Lung Cancer3
  • Adjuvant Drug Therapy1
  • First-line Advanced NSCLC Patients1
  • eGFR1

Other3 trials

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
Phase 2
Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies
Phase 1
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
Phase 2

Little Rock, Arkansas1 trial

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.